| Property | Value |
|---|
|
?:abstract
|
-
Background Protection of healthcare providers (HCP) has been a serious challenge in the management of patients during the COVID-19 pandemic. Additional physical barriers have been created to enhance personal protective equipment (PPE). In this study, user acceptability of two novel barriers were evaluated and barriers were compared during airway management. Methods An open label, double armed simulation pilot study was conducted. Each participant performed bag-mask ventilation and endotracheal intubation using a GlideScope in two scenarios: (1) PPE donned, followed by (2) PPE donned plus the addition of either the isolation chamber (IC) or aerosol box (AB). Endotracheal intubation using videolaryngoscopy was timed. Participants completed pre- and post- simulation questionnaires. Results 29 participants from the Department of Anesthesia were included in the study. Pre- and post- simulation questionnaire responses supported acceptance of additional barriers. There was no significant difference in intubating times across all groups (PPE vs IC 95% CI, 26.3-35.1; PPE vs AB 95% CI, 25.9-35.5; IC vs AB 95% CI, 23.6-39.1). Comparison of post-simulation questionnaire responses between IC and AB showed no significant difference. Participants did not find the additional barriers negatively affected communication, visualization or maneuverability. Conclusions Overall, the IC and AB were comparable, and there was no negative impact on performance under testing conditions. Our study suggests the positive acceptance of additional patient protection barriers by anesthesia providers during airway management.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
|
|
?:journal
|
-
Korean_journal_of_anesthesiology
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Patient barrier acceptance during airway management among anesthesiologists: A simulation pilot study.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}